Moderna
MRNA
#1355
Rank
S$20.94 B
Marketcap
S$53.62
Share price
-0.82%
Change (1 day)
7.89%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: S$20.94 Billion

As of February 2026 Moderna has a market cap of S$20.94 Billion. This makes Moderna the world's 1355th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026S$20.94 B33.85%
2025S$15.65 B-25.43%
2024S$20.99 B-58.08%
2023S$50.07 B-45.87%
2022S$92.50 B-33.55%
2021S$139.21 B154.55%
2020S$54.69 B516.25%
2019S$8.87 B29.38%
2018S$6.85 B

End of Day market cap according to different sources

On Feb 3rd, 2026 the market cap of Moderna was reported to be:

S$20.94 Billion
by Nasdaq info icon info icon
S$20.94 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$713.53 B 3,305.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$365.33 B 1,643.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$367.61 B 1,654.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
S$0.71 B-96.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$3.78 B-81.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
S$1.05 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$59.05 B 181.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$12.83 B-38.74%๐Ÿ‡บ๐Ÿ‡ธ USA